There are currently 53 active clinical trials seeking participants for COVID19 research studies. The states with the highest number of trials for COVID19 participants are Florida, Texas, California and New York.
Outpatient Treatment With Anti-Coronavirus Immunoglobulin
NCT04910269
Recruiting
The primary objective of the Outpatient Treatment with Anti-Coronavirus Immunoglobulin (OTAC) (INSIGHT 012) trial is to compare the safety and efficacy of a single infusion of anti-COVID-19 hyperimmune intravenous immunoglobulin (hIVIG) versus placebo among adults with recently diagnosed severe acute respiratory syndrome - coronavirus 2 (SARS-CoV2) infection who do not require hospitalization. The primary endpoint of this double-blind randomized trial is a five-category ordinal outcome that asse... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
06/21/2024
Locations: MedStar Health Research Institute, Washington, District of Columbia +45 locations
Conditions: COVID, SARS-CoV2 Infection, Covid19
Register for Updates
REsearching Covid-19 Outcomes in Diabetes (RECODE)
NCT04805970
Recruiting
The purpose of this study is to observe any changes that may occur to certain organs following a confirmed diagnosis of COVID-19 in people with and without diabetes.
Gender:
All
Ages:
18 years and above
Trial Updated:
06/20/2024
Locations: AdventHealth Translational Research Institute, Orlando, Florida
Conditions: Covid19, Diabetes
Register for Updates
Conversations You Want About Corona Virus Disease (COVID-19)
NCT05191420
Recruiting
Web-enabled virtual topical guide: develop virtual conversations for each concern and intensity level
Gender:
All
Ages:
18 years and above
Trial Updated:
06/04/2024
Locations: Wake Forest Health Sciences, Winston-Salem, North Carolina
Conditions: Covid19
Register for Updates
A Study of Baricitinib (LY3009104) in Children With COVID-19
NCT05074420
Recruiting
The purpose for this study is to determine if the study drug baricitinib is effective and safe in hospitalized pediatric participants with Coronavirus disease 2019 (COVID -19) and to confirm the dose.
Gender:
All
Ages:
Between 2 years and 18 years
Trial Updated:
05/27/2024
Locations: Arnold Palmer Hospital for Children, Orlando, Florida +19 locations
Conditions: Covid19, Corona Virus Infection
Register for Updates
Defibrotide for the Treatment of Severe COVID-19
NCT04652115
Recruiting
The goal of this study is to evaluate the safety and feasibility of defibrotide in COVID-19 pneumonia.
Gender:
All
Ages:
Between 18 years and 100 years
Trial Updated:
05/09/2024
Locations: Brigham and Women's Hospital, Boston, Massachusetts
Conditions: Covid19
Register for Updates
Evaluation of Aerosol in a Dental Clinic
NCT04659928
Recruiting
The purpose of this study is to evaluate the effectiveness of external evacuation units and mouth rinses during aerosol generating procedures in a dental clinic and to determine the risk level to the dental practitioners during aerosol generating procedures.
Gender:
All
Ages:
18 years and above
Trial Updated:
05/08/2024
Locations: The University of Texas Health Science Center at Houston, Houston, Texas
Conditions: Covid19
Register for Updates
Evaluate Long Term Cardiovascular and Pulmonary Complications After COVID-19 With Point of Care Ultrasound
NCT04756193
Recruiting
We hypothesize that recovered COVID-19 patients suffer long term cardiovascular and pulmonary complications, which can be detected by point of care ultrasound. The goal is to comprehensively delineate the long term cardiovascular and pulmonary ultrasound findings in recovered COVID-19 patients, identify risks factors for prolonged heart/lung injury, evaluate long term effects of applied treatment, and assess late medication/vaccine side effects in COVID-19 patients.
Gender:
All
Ages:
18 years and above
Trial Updated:
05/07/2024
Locations: University of Louisville Health, Louisville, Kentucky
Conditions: Covid19, Echocardiography, Ultrasound
Register for Updates
The Burden of COVID-19 Survivorship
NCT04913129
Recruiting
This research study is being done to find out what the longer-term physiological consequences of COVID-19 are, and to determine if exercise therapy can help improve lung function, heart function and overall fitness, and reduce symptoms in people recovering from SARS-CoV-2.
Gender:
All
Ages:
Between 21 years and 75 years
Trial Updated:
03/27/2024
Locations: Mayo Clinic in Florida, Jacksonville, Florida
Conditions: Covid19
Register for Updates
COVID-19 Risk Assessment for Hospitalization Outcomes and Epidemiology Efficacy
NCT04678193
Recruiting
Researchers are creating real-time epidemiology registry to evaluate the efficacy of COVID-19 subject risk assessment scores based on recording of symptoms, biomarkers, chronic illness and mental health assessments with digital technology using wearables and mobile app tools. Researchers aim to study in Phase 1, epidemiological variations in COVID-19 presentation in both PCR positive and negative subjects in the registry. Assessment of variables, predictive modeling of variables that impact seve... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
03/19/2024
Locations: Multiple Locations, Phoenix, Arizona +2 locations
Conditions: Covid19
Register for Updates
KIDney Injury in Times of COVID-19 (KIDCOV)
NCT04705766
Recruiting
There is an unmet need to evaluate the impact of sub-clinical/mild COVID19 disease in the outpatient setting on prevalent and incident renal injury, as this data is currently unavailable. To capture the diversity of race/ethnic risk and COVID19 related municipal shelter-in-place guidance, the investigators will enroll COVID19-negative and COVID19-positive samples balanced by race/ethnicity from 3 different states, California, Michigan, and Illinois. Study endpoints will be assayed from urine sam... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
03/14/2024
Locations: UCSF, San Francisco, California +2 locations
Conditions: SARS-CoV Infection, Covid19, Corona Virus Infection, Acute Kidney Injury, Kidney Injury
Register for Updates
Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs
NCT04924803
Recruiting
People who inject drugs (PWID) experience disproportionate risk of being infected with SARS-CoV-2, the virus that causes COVID-19, yet due to stigma, fear of mistreatment, and other factors, PWID are far less likely to be vaccinated compared to other populations. In response, we propose to continue our collaboration with a prominent community based organization serving African American and Latino PWID. Our project will explore baseline hesitancy to vaccinate among PWID, identify barriers to vacc... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
03/13/2024
Locations: OnPoint NYC, New York, New York
Conditions: Covid19
Register for Updates
COVID-19 Registry to Assess Frequency, Risk Factors, Management, and Outcomes of Arterial and Venous Thromboembolic Complications
NCT04535128
Recruiting
Novel coronavirus 2019 (COVID-19) has emerged as a major international public health concern. While much of the morbidity and mortality associated with COVID-19 has been attributed to acute respiratory distress syndrome (ARDS) or end-organ failure, emerging data suggest that disorders of coagulation, in particular hypercoagulability and venous thromboembolism (VTE), may represent an additional major, and possibly preventable, complication (Wu C, et al. JAMA Intern Med. 2020 Mar 13. [Epub ahead o... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
03/03/2024
Locations: Brigham and Women's Hospital, Boston, Massachusetts
Conditions: Covid19, Thrombosis Embolism, DVT, Pulmonary Embolism, Myocardial Infarction, Stroke
Register for Updates